Skip to main content

Table 1 Characteristics of study population

From: Variation in serum urate levels in the absence of gout and urate lowering therapy

Characteristic Study population (n = 85) Normouricemic at Screening (n = 72) Hyperuricemic at Screening (n = 13)
Age at Enrollment (mean ± SD) 27.8 ± 7.0 27.9 ± 7.1 27.4 ± 7.3
Sex
 Male 52 (61%) 39 (54%) 13 (100%)
 Female 33 (39%) 33 (45%) 0 (0%)
Race/Ethnicity
 White 45 (53%) 37 (51%) 8 (62%)
 African-American 35 (41%) 32 (45%) 3 (23%)
 Other 5 (6%) 3 (4%) 2 (15%)
BMI (mean ± SD) 31.1 ± 7.9 30.8 ± 8.1 32.4 ± 6.6
Screening Serum urate (mean ± SD, mg/dL) 5.8 ± 1.2   
 Men 6.4 ± 1.0   
 Women 4.9 ± 0.7   
  1. SD Standard deviation, mg/dL Milligrams per deciliter